RxDoctor Payments Data

Thomas Cook, DO

Orthopaedic Surgery · Dayton, OHNPI 1942281308

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.4%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Maxx Orthopedics, Inc. at 46.3% of the total. Reporting peaked in 2019 at $67,451 and has fallen 91.0% since, to $6,060 in 2025. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$186,965in general payments, 2019–2025

Across 82 payments — averaging $2280.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Maxx Orthopedics, Inc.$87K
  • UOC USA Inc$45K
  • Fuse Medical, Inc.$27K
  • Encore Medical, LP$26K
  • Orthalign Inc$531
  • Nextstep Arthropedix, LLC$261
  • plus $1K from 12 others
$5,427in research payments, 2019–2025

Across 2 payments — averaging $2713.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$5K

What the payments were for

  • Royalty or licence$29,99716%
  • Consulting fees$92,39749%
  • Speaking & faculty fees$23,40013%
  • Travel & lodging$1,2061%
  • Food & beverage$18,94310%
  • Education$21,02311%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$186,965 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.

See all orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$252,909
Medicare patients
307
Services billed
2,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib215$7,306
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen57$600
Doxycycline Hyclate20$437
Oxycodone Hcl49$344
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$316
Ketorolac Tromethamine25$276
Prednisone14$144
Cephalexin16$114

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →